Follitropin beta

Drug Profile

Follitropin beta

Alternative Names: Follistim; Follistim AQ Cartridge; ORG-32489; Puregon; Recombinant human follicle-stimulating hormone - Organon; rh-FSH - Organon

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Organon
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Female infertility; Hypogonadism

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 28 Feb 2017 Merck has patent protection for follitropin beta in the US, Europe and Japan (Merck Annual report 2016)
  • 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top